Shuangcheng Pharmaceutical: The reduction plan by Vice President Yao Zhong has been completed, with 40,500 shares sold.

Shuangcheng Pharmaceutical announced that the share reduction plan of Vice President Yao Zhong has been completed. On August 4, 2026, he reduced his holdings by 40,500 shares through centralized bidding, accounting for 0.01% of the total share capital, with an average reduction price of 9.65 yuan per share. After this reduction, Yao Zhong's holdings decreased to 121,500 shares, representing 0.03% of the total share capital. The shares sold were part of the restricted stock granted under the company's 2021 incentive plan that have been unlocked. This reduction will not lead to a change in company control and is not in violation of any regulations.